Weight Watchers International, Inc. is a well-known provider of weight management services. The company has market cap of $1.35 billion. The Firm operates globally through a network of Company-owned and franchise operations. It has a 20.75 P/E ratio. The Company’s branded services and products include meetings conducted by its franchisees, digital weight management products provided through its Websites, mobile sites and applications, products sold at meetings, licensed products sold in retail channels and magazine subscriptions and other publications.
Analysts expect Pulse Biosciences Inc (NASDAQ:PLSE) to report $0.00 EPS on May, 4 after the close. It closed at $23.97 lastly. It is down 273.95% since September 26, 2016 and is uptrending. It has outperformed by 262.53% the S&P500.
Pulse Biosciences, Inc., formerly Electroblate, Inc., is a development-stage medical device firm using a platform technology called Nano-Pulse Electro-Signaling . The company has market cap of $344.82 million. NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. It currently has negative earnings. NPES provides treatment in a range of dermatology and aesthetic applications.
Artal Group S.A. holds 7.48% of its portfolio in Weight Watchers International, Inc. for 29.44 million shares. Permit Capital Llc owns 251,150 shares or 1.97% of their US portfolio. Moreover, 12 West Capital Management Lp has 1.22% invested in the company for 598,388 shares. The New York-based Indus Capital Partners Llc has invested 0.75% in the stock. Melvin Capital Management Lp, a New York-based fund reported 1.69 million shares.
Since January 1, 0001, it had 0 buys, and 1 sale for $80,186 activity.
About 46,350 shares traded. Weight Watchers International, Inc. (NYSE:WTW) has risen 104.73% since September 26, 2016 and is uptrending. It has outperformed by 93.31% the S&P500.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.